Gordon Strickland is an accomplished business executive with extensive experience in leadership and governance. Currently serving as an Independent Director and Chair of the Audit Committee at NeuroBo Pharmaceuticals, Inc. since January 2022, Strickland has a diverse background that includes roles such as Guest Lecturer at Vanderbilt University School of Engineering and Consultant at Adaptigent. From 2007 to 2019, Strickland held prominent positions as Chairman of the Board of Directors and CEO at Ampex Corporation, overseeing significant organizational changes. Additionally, Strickland has served on various boards, including Applied Technical Services and Cardiff Holdings Corp. Strickland's educational credentials include a Bachelor of Arts in Economics from Yale University and an MBA in Finance from The Wharton School.
This person is not in the org chart
This person is not in any teams